Surmodics, Inc. (SRDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
30.09+0.80 (+2.73%)
At close: 4:00 PM EDT
People also watch:
VASCTECHSPNCICUIVIVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open29.34
Prev Close29.29
Bid30.05 x 500
Ask30.08 x 100
Day's Range29.02 - 30.28
52wk Range17.45 - 30.28
1y Target EstN/A
Market Cap392.55M
P/E Ratio (ttm)44.98
Beta0.66
Volume36,938
Avg Vol (3m)56,925
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire2 months ago

    Surmodics to Present at 5th Annual InvestMNt Conference on August 24

    Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that the Company will present at the 2016 InvestMNt conference sponsored by CFA Society Minnesota.

  • SurModics, Inc. :SRDX-US: Earnings Analysis: Q3, 2016 By the Numbers : August 10, 2016
    Capital Cube2 months ago

    SurModics, Inc. :SRDX-US: Earnings Analysis: Q3, 2016 By the Numbers : August 10, 2016

    Categories: Yahoo Finance Click here to see latest analysis SurModics, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of SurModics, Inc. – Nektar Therapeutics, Thermo Fisher Scientific Inc., Heron Therapeutics Inc, Abbott Laboratories, Johnson & Johnson, PerkinElmer, Inc. and Alkermes Plc (NKTR-US, TMO-US, HRTX-US, ABT-US, JNJ-US, ... Read more (Read more...)

  • Business Wire2 months ago

    Surmodics IVD Launches Breakthrough StabilBlock® Immunoassay Stabilizer

    Surmodics, Inc. , the global leader in chemical components for in vitro diagnostic tests and microarrays, has announced the launch and immediate availability of StabilBlock®, its most advanced Immunoassay Stabilizer.